TKT and cancer: GCV alone had negligible effect on the cell viability (Fig. 6A), whereas transfection of the modified SB (pT.hTp.HSV-tk.Con) system following administration of GCV significantly decreased cancer cell viability in a dose-dependent manner (Fig. 6B).